WHO WE ARE
Created in May 2018, Zionexa is an international company developing and commercializing Molecular Imaging Companion Diagnostics (CDx) for targeted therapies in Oncology aimed to improve patients’ pathway and quality of life.
Zionexa is a spin-off of Cyclopharma, a radiopharmaceutical company producing and commercializing biomarkers in France.
We develop Molecular Imaging CDx for targeted therapies that will transform oncology by improving the patient’s pathway and quality of life. Within a PET Scan (Positron Emission Tomography) exam, biomarkers help Oncologists and Nuclear Medicine Physicians to personalize the treatment, based on the localization and characteristics of the tumors.
MEET OUR TEAM
Meet our team of experts in CDx Imaging for Oncology: